Litcius/Paper detail

Genetic recombination of poly(<scp>l</scp>-lysine) functionalized apoferritin nanocages that resemble viral capsid nanometer-sized platforms for gene therapy

Haiqin Huang, Shirui Yuan, Zhuo Ma, Peng Ji, Xiaonan Ma, Zhenghong Wu, Xiaole Qi

2020Biomaterials Science28 citationsDOI

Abstract

Currently, bioengineered apoferritin nanocages with flexible protein shells and functionalized modifications have become an attractive approach for efficient anti-tumor therapy. Here, we modified the N-terminus of H-chain subunits in apoferritin with different amounts of lysine via genetic recombination to obtain a poly(l-lysine) modified H-chain apoferritin (nL-HFn) nanocage for siRNA delivery and gene therapy. To achieve excellent cellular affinity and uptake, the nanocarriers were internalized through transferrin receptor-mediated endocytosis, then escaped from the endosome for cytoplasmic transport. Compared with natural apoferritin, the siRNA-loaded genetic recombination NPs modified with lysine exhibit stronger RNA-interference and antitumor efficiency both in vitro and in 4T1 tumor model mice. Therefore, bioengineered apoferritin nanocages modified with lysine might be a promising platform for nucleic acid drug delivery.

Topics & Concepts

NanocagesCapsidLysineChemistryRecombinationVirus-like particleGeneBiochemistryRecombinant DNAAmino acidCatalysisRNA Interference and Gene DeliveryVirus-based gene therapy researchAdvanced biosensing and bioanalysis techniques